IGF1 Antikörper (Isoform 4)
Kurzübersicht für IGF1 Antikörper (Isoform 4) (ABIN4889287)
Target
Alle IGF1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Isoform 4
-
Spezifität
- Reacts with human Isoform 4 of Insulin-like growth factor I
-
Aufreinigung
- Purified (protein A)
-
Immunogen
- Synthetic peptide derived from Isoform 4 of Insulin-like growth factor I
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
- WB : 1/500 to 1/5 000 - IHC : 1/100 to 1/2 000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Must be reconstituted in distilled water.
-
Konzentration
- 1 mg/mL
-
Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Haltbarkeit
- 24 months
-
-
- IGF1 (Insulin-Like Growth Factor 1 (IGF1))
-
Andere Bezeichnung
- Insulin-Like Growth Factor I (IGF-I)
-
Hintergrund
- Insulin-like growth factor I (IGF-I)is involved in DNA replication, signal transduction, cellular componant mobility...
-
Pathways
- RTK Signalweg, Intracellular Steroid Hormone Receptor Signaling Pathway, Peptide Hormone Metabolism, Hormone Activity, Regulation of Intracellular Steroid Hormone Receptor Signaling, Regulation of Hormone Metabolic Process, Regulation of Hormone Biosynthetic Process, Stem Cell Maintenance, Glycosaminoglycan Metabolic Process, Regulation of Carbohydrate Metabolic Process, Autophagie, Smooth Muscle Cell Migration, Activated T Cell Proliferation, Positive Regulation of fat Cell Differentiation
Target
-